• 1
    Van de Putte LB, van Gestel AM, van Riel PL. Early treatment of rheumatoid arthritis: rationale, evidence, and implications. Ann Rheum Dis 1998; 57: 5112.
  • 2
    Irvine S, Munro R, Porter D. Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis 1999; 58: 5103.
  • 3
    Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002; 61: 2907.
  • 4
    Emery P, Marzo H, Proudman S. Management of patients with newly diagnosed rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 2731.
  • 5
    Aletaha D, Eberl G, Nell VP, Machold KP, Smolen JS. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years. Ann Rheum Dis 2002; 61: 6304.
  • 6
    Saraux A, Maillefert JF, Fautrel B, Flipo RM, Kaye O, Lafforgue P, et al. Laboratory and imaging studies used by French rheumatologists to determine the cause of recent onset polyarthritis without extra-articular manifestations. Ann Rheum Dis 2002; 61: 6269.
  • 7
    Henke CJ, Epstein WV. Practice variation in rheumatologists' encounters with their patients who have rheumatoid arthritis. Med Care 1991; 29: 799812.
  • 8
    Wennberg JE, Barnes BA, Zubkoff M. Professional uncertainty and the problem of supplier-induced demand. Soc Sci Med 1982; 16: 81124.
  • 9
    Wennberg JE. Dealing with medical practice variations: a proposal for action. Health Aff (Millwood) 1984; 3: 632.
  • 10
    Eddy DM. Variations in physician practice: the role of uncertainty. Health Aff (Millwood) 1984; 3: 7489.
  • 11
    Yelin E, Callahan LF, National Arthritis Data Work Groups. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995; 38: 135162.
  • 12
    Badley EM. The impact of disabling arthritis. Arthritis Care Res 1995; 8: 2218.
  • 13
    Coyte PC, Asche CV, Croxford R, Chan B. The economic cost of musculoskeletal disorders in Canada. Arthritis Care Res 1998; 11: 31525.
  • 14
    Guillemin F. Les incapacités et les conséquences des maladies rhumatismales. J l'AFLAR 1998; 98 Suppl: 36.
  • 15
    Lanes SF, Lanza LL, Radensky PW, Yood RA, Meenan RF, Walker AM, et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 1997; 40: 147581.
  • 16
    Yelin E. The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates. J Rheumatol Suppl 1996; 44: 4751.
  • 17
    Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997; 24: 71925.
  • 18
    van Jaarsveld CH, Jacobs JW, Schrijvers AJ, Heurkens AH, Haanen HC, Bijlsma JW. Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study. Br J Rheumatol 1998; 37: 83747.
  • 19
    Daures JP, Sibilia J, Guillemin F, Durieux S, Lafuma A, Fagnani F, et al. PRACTIS: etude médicoéconomique des caractéristiques et de la prise en charge de la polyarthrite en France [abstract]. Rev Rhum 2001; 68: 966.
  • 20
    Newhall-Perry K, Law NJ, Ramos B, Sterz M, Wong WK, Bulpitt KJ, et al, Western Consortium of Practicing Rheumatologists. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. J Rheumatol 2000; 27: 115663.
  • 21
    Jonsson D, Husberg M. Socioeconomic costs of rheumatic diseases: implications for technology assessment. Int J Technol Assess Health Care 2000; 16: 1193200.
  • 22
    Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 2000; 39: 2833.
  • 23
    Pugner KM, Scott DI, Holmes JW, Hieke K. The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum 2000; 29: 30520.
  • 24
    Maravic M, Bozonnat MC, Sevezan A, Gasqueres D, Pastor J, Pere M, et al. Preliminary evaluation of medical outcomes (including quality of life) and costs in incident RA cases receiving hospital-based multidisciplinary management. Joint Bone Spine 2000; 67: 42533.
  • 25
    Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA 2000; 283: 171522.
  • 26
    Suarez-Almazor ME, Belseck E, Russell AS, Mackel JV. Use of lumbar radiographs for the early diagnosis of low back pain: proposed guidelines would increase utilization. JAMA 1997; 277: 17826.
  • 27
    Kasper JF, Mulley AG Jr, Wennberg JE. Developing shared decision-making programs to improve the quality of health care. QRB Qual Rev Bull 1992; 18: 18390.